The ROC analyses revealed that areas under the ROC curves for NAA/Cr and Glx/Cr were 0.808 and 0.786, respectively, in distinguishing IDH-mutant from IDH wild-type gliomas. This evidence concerns the gene IDH1 and central nervous system cancer.